Your browser doesn't support javascript.
loading
Identification of Tissue Types and Gene Mutations From Histopathology Images for Advancing Colorectal Cancer Biology.
Jiang, Yuqi; Chan, Cecilia K W; Chan, Ronald C K; Wang, Xin; Wong, Nathalie; To, Ka Fai; Ng, Simon S M; Lau, James Y W; Poon, Carmen C Y.
Affiliation
  • Jiang Y; Department of SurgeryThe Chinese University of Hong Kong Hong Kong SAR.
  • Chan CKW; Division of Vascular and General Surgery, Department of Surgery, Prince of Wales HospitalThe Chinese University of Hong Kong Hong Kong SAR.
  • Chan RCK; Department of Anatomical and Cellular PathologyThe Chinese University of Hong Kong Hong Kong SAR.
  • Wang X; Department of SurgeryThe Chinese University of Hong Kong Hong Kong SAR.
  • Wong N; Department of SurgeryThe Chinese University of Hong Kong Hong Kong SAR.
  • To KF; Department of Anatomical and Cellular PathologyThe Chinese University of Hong Kong Hong Kong SAR.
  • Ng SSM; Division of Colorectal Surgery, Department of SurgeryThe Chinese University of Hong Kong Hong Kong SAR.
  • Lau JYW; Division of Vascular and General Surgery, Department of Surgery, Prince of Wales HospitalThe Chinese University of Hong Kong Hong Kong SAR.
  • Poon CCY; GMed IT Ltd. Hong Kong SAR.
IEEE Open J Eng Med Biol ; 3: 115-123, 2022.
Article in En | MEDLINE | ID: mdl-35937101
ABSTRACT

Objective:

Colorectal cancer (CRC) patients respond differently to treatments and are sub-classified by different approaches. We evaluated a deep learning model, which adopted endoscopic knowledge learnt from AI-doscopist, to characterise CRC patients by histopathological features.

Results:

Data of 461 patients were collected from TCGA-COAD database. The proposed framework was able to 1) differentiate tumour from normal tissues with an Area Under Receiver Operating Characteristic curve (AUROC) of 0.97; 2) identify certain gene mutations (MYH9, TP53) with an AUROC > 0.75; 3) classify CMS2 and CMS4 better than the other subtypes; and 4) demonstrate the generalizability of predicting KRAS mutants in an external cohort.

Conclusions:

Artificial intelligent can be used for on-site patient classification. Although KRAS mutants were commonly associated with therapeutic resistance and poor prognosis, subjects with predicted KRAS mutants in this study have a higher survival rate in 30 months after diagnoses.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: IEEE Open J Eng Med Biol Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: IEEE Open J Eng Med Biol Year: 2022 Document type: Article